EHAB Stock Analysis: Buy, Sell, or Hold?

EHAB - Enhabit, Inc.

SERVICES-HOME HEALTH CARE SERVICES
$14.05
0.39 (2.86%) ▲
5d: +3.16%
30d: +3.23%
90d: +49.79%
BUY
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026

Get Alerted When EHAB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: EHAB shows positive signals but monitor for confirmation. Market pricing in 6.8% annual growth which appears achievable. Moderate conviction.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$13.72
Based on 3.5% avg growth
INTRINSIC VALUE TODAY
$8.52
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: EHAB is currently trading at $14.05, which is considered slightly high relative to its 30-day fair value range of $12.81 to $14.10. From a valuation perspective, the stock is trading at a premium (Forward PE: 22.6) compared to its historical average (18.6). At these levels, the market is pricing in 6.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, EHAB is in a strong uptrend. The price is approaching resistance at $14.04. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $12.81 - $14.10
Company Quality Score 60/100 (BUY)
Volume Confirmation HIGH
Confidence Score 60.5%

All Signals

  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($13.80)
  • NEUTRAL: PE elevated vs history but 6.8% growth expectation is conservative given 8668% recent growth

Fair Price Analysis

30-Day Fair Range $12.81 - $14.10
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $13.60
Resistance Level $14.04
Current Trend Strong Uptrend
Technical data as of Mar 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) 22.62
Wall Street Target $13.80 (-1.8%)
Revenue Growth (YoY) 4.7%
Earnings Growth (YoY) 8667.5%
Profit Margin -0.4%
Valuation Premium vs History +6.8% premium
PE vs Historical 22.6 vs 18.6 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +6.8% (market-implied from PE analysis)
1-Year Target $15.01 (+7%)
2-Year Target $16.03 (+14%)
3-Year Target $17.12 (+22%)
3-Yr Target (if PE normalizes) (PE: 23→19) PE COMPRESSION $14.07 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.6, Growth: 3.0%) $15.33 (+9%)
Base: (SPY PE: 22.4, Growth: 3.0%) $15.15 (+8%)
Bear: (PE: 18.6, Growth: 3.0%) $12.61 (-10%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 31, 2026 12:09 AM ET
Data refreshes hourly during market hours. Next update: 1:09 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Collin Mcquiddy SELL 1403 shares 2026-03-11
Julie Diane Jolley SELL 2793 shares 2026-03-09

Unlock Insider Activity

See real-time buying/selling by company executives for EHAB.

Create Free Account

Already have an account? Log In

Top Rated Medical Care Facilities Stocks

Top-rated stocks in Medical Care Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
THC
Tenet Healthcare Corpora…
STRONG BUY
22 analysts
$261 62 BUY
HCA
HCA Holdings Inc
BUY
25 analysts
$543 64 BUY
EHC
Encompass Health Corp
STRONG BUY
12 analysts
$143 56 HOLD
CMPS
Compass Pathways Plc
STRONG BUY
11 analysts
$22 48 HOLD
ADUS
Addus HomeCare Corporati…
STRONG BUY
11 analysts
$140 54 HOLD

More Analysis for EHAB

EHAB Technical Chart EHAB Price Prediction EHAB Earnings Date EHAB Investment Advisor EHAB Fair Price Analyzer EHAB Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals